Hotel Edison

Graybug to Present at the 2022 OIS Retina Innovation Summit

Retrieved on: 
Wednesday, July 6, 2022
Timolol, Optic nerve, Retinitis pigmentosa, Patient, Glycogen storage disease, Lists of diseases, CGMP, Johns Hopkins School of Medicine, GLOBE, AAV, Retina, Hotel Edison, Investor, Technology, Edison Theatre, Cornea, AMD, Time, OIS, ODD, Diabetic retinopathy, Pharmaceutical industry

BALTIMORE, July 06, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced a platform presentation at the upcoming Ophthalmology Innovation Source (OIS) Retina Innovation Summit, to be held in New York City on July 13, 2022.

Key Points: 
  • BALTIMORE, July 06, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced a platform presentation at the upcoming Ophthalmology Innovation Source (OIS) Retina Innovation Summit, to be held in New York City on July 13, 2022.
  • Information about the event is listed below and available on the OIS Retina website.
  • Graybug is a clinical-stage biopharmaceutical company focused on developing transformative medicines for ocular diseases.
  • Founded in 2011 based on technology licensed from the Johns Hopkins University School of Medicine, Graybug has offices in Redwood City, California and in Baltimore, Maryland.

TI Health CEO Honored with Top Women in Media Award

Retrieved on: 
Saturday, October 2, 2021
Mass, Solution, Map, Hotel Edison, Multimedia, Entrepreneurship, Omnichannel, Marketing, Affine Analytics, Australian Interactive Media Industry Association, Life, Woman, Leadership, Machine learning, Pharmaceutical industry

NEW YORK, Oct. 1, 2021 /PRNewswire/ -- TI Health CEO Erin DeRuggiero is being recognized for her outstanding contribution to the Media Industry and unrelenting commitment to entrepreneurship, leadership and innovation.

Key Points: 
  • NEW YORK, Oct. 1, 2021 /PRNewswire/ -- TI Health CEO Erin DeRuggiero is being recognized for her outstanding contribution to the Media Industry and unrelenting commitment to entrepreneurship, leadership and innovation.
  • The awards ceremony and honoree luncheon will take place on December 1st, at the Hotel Edison in New York, where other women in media are set to be celebrated across five different categories.
  • TI Healthis a data driven marketing and predictive analytics company, delivering omni-channel insights and activation solutions for healthcare companies and pharmaceutical brands.
  • For more information about TI Health's products and services, visit http://www.tihealth.com
    View original content to download multimedia: https://www.prnewswire.com/news-releases/ti-health-ceo-honored-with-top-...